About Michael Koeris
Form D filings for Xeno Biosciences from 2018 to 2023 list Michael Koeris as director.
Michael Koeris first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Koeris in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Koeris works with at each company, as listed on that company's latest Form D.
Xeno Biosciences Inc. · Form D, Jan 5, 2023
DB
David Beno
Chief Executive Officer and director
JA
Jeffrey Arnold
Director
TH
Tom Hughes
Director
SR
Stan Rose
Director